Author

Yu Liu

University of Louisiana at MonroeORCID 0000-0002-7968-0162Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Yu Liu24 papers · University of Tennessee Health Science Center

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:chromatin & epigenetic regulation· 1 Approach:experimental assay· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Amanda Raphael· 1 shared Anish Ashok GuptaiD· 1 shared Celine Asbury· 1 shared Davorka Sekulić· 1 shared Lin KangiD· 1 shared Md Saqline MostaqiD· 1 shared Mohammad Nurul AminiD· 1 shared Pawel MichalakiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Amanda Raphael

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintNov 2, 2025

Suppression of Glucosylceramide Synthase Reverses Drug Resistance in Cancer Cells Harbor Homozygous p53 Mutants

Md Saqline Mostaq, Mohammad Nurul Amin, Amanda Raphael…·Yu Liu

This study shows that inhibiting glucosylceramide synthase (GCS) re-sensitizes drug-resistant cancer cells with homozygous p53 mutations to chemotherapy and reduces cancer stem cells.

1 citation

humanbulk RNA-seq

𝕏 PostBluesky